Search

Your search keyword '"Keunen J"' showing total 246 results
Start Over Author "Keunen J" Publication Year Range Last 50 years
246 results on '"Keunen J"'

2. Retinale vaatafwijkingen

Author

Keunen, J. E. E., Hooymans, J. M. M., van Leeuwen, Y., van Leeuwen, Y., editor, Van den Maegdenbergh, M., editor, van der Pol, B.A.E., editor, and de Waard, J., editor

Published
2016
Full Text
View/download PDF

4. Heat Treatment of Choroidal Melanomas

Author

Oosterhuis, J. A., Keunen, J. E. E., Korver, H. G. Journée-De, Brady, Luther W., editor, Heilmannn, H.-P., editor, Molls, M., editor, Sagerman, Robert H., editor, and Alberti, Winfried E., editor

Published
2003
Full Text
View/download PDF

6. Foveal densitometry and color matching in oligocone trichromacy

Author

Keunen, J. E. E., De Brabandere, S. R. S., Liem, A. T. A., Drum, B., editor, Adams, A. J., editor, Cavonius, C. R., editor, Dain, S. J., editor, Haegerstrom-Portnoy, G., editor, Kitahara, K., editor, Knoblauch, K., editor, Kurtenbach, A., editor, Lee, B. B., editor, Mollon, J., editor, Moreland, J. D., editor, Pokorny, J., editor, Sharpe, L. T., editor, Sperling, H. A., editor, Swanson, W. H., editor, and Zrenner, E., editor

Published
1995
Full Text
View/download PDF

11. Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years' experience

Author

Bartlema, Y M., Oosterhuis, J A., Korver, J G Journee-de, Tjho-Heslinga, R E., and Keunen, J E E

Subjects
Eye cancer -- Care and treatment, Health, Care and treatment
Abstract

Br J Ophthalmol 2003;87:1370-1373 Aim: To evaluate the results of combined plaque radiotherapy and transpupillary thermotherapy (TTT) in 50 consecutive patients 5 years after treatment. Methods: 50 adult patients with [...]

Published
2003

24. The PLACE trial: an open-label, multicenter, randomized controlled trial comparing half-dose photodynamic therapy with subthreshold micropulse laser for chronic central serous chorioretinopathy

Author

Boon, C. J. F., van Dijk, E. H. C., Fauser, S., Breukink, M. D., Blanco-Garavito, R., Groenewoud, J. M. M., Keunen, J. E. E., Peters, P. J. H., Dijkman, G., Souied, E. H., MacLaren, R. E., Querques, G., Downes, S. M., Hoyng, C. B., Boon, C. J. F., van Dijk, E. H. C., Fauser, S., Breukink, M. D., Blanco-Garavito, R., Groenewoud, J. M. M., Keunen, J. E. E., Peters, P. J. H., Dijkman, G., Souied, E. H., MacLaren, R. E., Querques, G., Downes, S. M., and Hoyng, C. B.

Published
2018

32. A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema

Author

Sultan, Mb, Zhou, D, Loftus, J, Dombi, T, Ice, Ks, Bird, A, D'Amico, D, Herson, J, Klein, R, Wallisch, M, de Gronckel, S, Danielson, L, Quinaz, E, Wang, K, Balbueno, S, Mikusova, B, Spiller, Hw, Cameron, P, Sawa, M, Wallace, S, Altaweel, M, Danis, R, Domalpally, A, Alexander, S, Corkery, E, Daywalt, M, Dohm, K, Endres, R, Goulding, A, Reimers, J, Susman, R, Wabers, H, Whilhelmson, T, White, J, Lim, L, Wong, T, Mitchell, P, Kralinger, M, Stur, M, Avila, M, Farah, M, Lavinsky, J, Maberly, D, Olivier, S, Rosemont, P, Dusova, J, Ernest, J, Fiser, I, Kolar, P, Rehak, J, Larsen, M, Berrod, Jp, Devin, F, Koenig Supiot, F, Massin, P, Soubrane, G, Dithmar, S, Holz, F, Joussen, A, Lappas, A, Bartz Schmidt KU, Spital, G, Wiedemann, P, Vergados, I, Azad, R, Jalali, S, Murthy, P, Nagpal, M, Bandello, F, Lanzetta, Paolo, Lattanzio, R, Menchini, U, Keunen, J, Figueira, J, Sarra, Gm, Trittibach, P, Brand, C, Talks, J, Carnevale, K, Ciulla, Ta, Connor, Tb, Elliott, D, Friberg, Tr, Garcia, Ca, Gonzalez, Vh, Gross, N, Halperin, Ls, Hudson HL 3rd, Kokame, G, Lit, E, Marcus, Dm, Patel, S, Pavan, P, Rosa, R, Sang, D, Singer, M, Varenhorst, Mp, Wells, J, Adamis, Ap, Betts, F, Burke, K, Cunningham ET Jr, Curtiss, K, Goldbaum, M, Guyer, Dr, Harrison, E, Katz, B, Liss, C, Masonson, H, O'Shaughnessy, D, Archer, R, Barbeito, R, Bojko, R, Borgstadt, M, Carlin, R, Chappell, P, Cobles, C, Culhane, J, Davisson, B, Elkins, M, Eveleth, D, Fernstrom, S, Franklin, K, Houghton, F, Edward Hume, H, Hilary Jones, J, Kirschner, K, Kwok, K, Lee, P, Littel, A, Lock, K, Lyster, S, Machado, P, Maeda Chubachi, T, Maute, A, Mulvaney, A, O'Neill, B, Paggiarino, D, Quinto Olegario, K, Pleil, A, Stewart, C, Wilson, G, Yan, E, and Zurlo, M.

Subjects
Adult, Male, Vascular Endothelial Growth Factor A, medicine.medical_specialty, Visual acuity, Fundus Oculi, Pegaptanib, Eye disease, Population, Visual Acuity, Macular Edema, law.invention, Young Adult, Randomized controlled trial, law, Ophthalmology, Evaluation of complex medical interventions Genomic disorders and inherited multi-system disorders [NCEBP 2], medicine, Pegaptanib Sodium, Humans, Macula Lutea, Fluorescein Angiography, Adverse effect, education, Aged, Aged, 80 and over, education.field_of_study, Diabetic Retinopathy, Dose-Response Relationship, Drug, business.industry, Aptamers, Nucleotide, Middle Aged, medicine.disease, Clinical trial, Treatment Outcome, Anesthesia, Intravitreal Injections, Female, medicine.symptom, business, medicine.drug
Abstract

Item does not contain fulltext PURPOSE: To confirm the safety and compare the efficacy of intravitreal pegaptanib sodium 0.3 mg versus sham injections in subjects with diabetic macular edema (DME) involving the center of the macula associated with vision loss not due to ischemia. DESIGN: Randomized (1:1), sham-controlled, multicenter, parallel-group trial. PARTICIPANTS: Subjects with DME. INTERVENTION: Subjects received pegaptanib 0.3 mg or sham injections every 6 weeks in year 1 (total = 9 injections) and could receive focal/grid photocoagulation beginning at week 18. During year 2, subjects received injections as often as every 6 weeks per prespecified criteria. MAIN OUTCOME MEASURES: The primary efficacy endpoint was the proportion gaining >/= 10 letters of visual acuity (VA) from baseline to year 1. Safety was monitored throughout. RESULTS: In all, 260 (pegaptanib, n = 133; sham, n = 127) and 207 (pegaptanib, n = 107; sham, n = 100) subjects were included in years 1 and 2 intent-to-treat analyses, respectively. A total of 49 of the 133 (36.8%) subjects from the pegaptanib group and 25 of the 127 (19.7%) from the sham group experienced a VA improvement of >/= 10 letters at week 54 compared with baseline (odds ratio [OR], 2.38; 95% confidence interval, 1.32-4.30; P = 0.0047). For pegaptanib-treated subjects, change in mean VA from baseline by visit was superior (P

Published
2011

33. Changes in vision- and health-related quality of life in patients with diabetic macular edema treated with pegaptanib sodium or sham

Author

Loftus, Jv, Sultan, Mb, Pleil, Am, Lim, L, Wong, T, Mitchell, P, Kralinger, M, Avila, M, Farah, M, Lavinsky, J, Maberly, D, Dusova, J, Ernest, J, Fiser, I, Kolar, P, Rehak, J, Larsen, M, Berrod, Jp, Devin, F, Koenig Supiot, F, Soubrane, G, Dithmar, S, Holz, F, Joussen, A, Lappas, A, Bartz Schmidt KU, Spital, G, Wiedemann, P, Vergados, I, Azad, R, Jalali, S, Murthy, P, Nagpal, M, Bandello, F, Lanzetta, Paolo, Lattanzio, R, Keunen, J, Figueira, J, Sarra, Gm, Trittibach, P, Brand, C, Talks, J, Carnevale, K, Ciulla, Ta, Connor, Tb, Elliott, D, Mahmoud, T, Friberg, Tr, Garcia, Ca, Gonzalez, Vh, Gross, N, Halperin, Ls, Hudson HL 3rd, Kokame, G, Lit, E, Marcus, Dm, Patel, S, Pavan, P, Rosa, R, Sang, D, Sell, C, Singer, M, Varenhorst, Mp, Wells, J, Adamis, Ap, Betts, F, Burke, K, Cunningham ET Jr, Curtiss, K, Goldbaum, M, Guyer, Dr, Harrison, E, Katz, B, Liss, C, Masonson, H, O'Shaughnessy, D, Archer, R, Barbeito, R, Bojko, R, Borgstadt, M, Carlin, R, Chappell, P, Cobles, C, Cobles, J, Davisson, B, Dombi, T, Elkins, M, Eveleth, D, Fernstrom, S, Franklin, K, Houghton, F, Hume, E, Ice, K, Jones, H, Kirschner, K, Kwok, K, Lee, P, Littel, A, Lock, K, Lyster, S, Machado, P, Maeda Chubachi, T, Maute, A, Mulvaney, A, O'Neill, B, Paggiarino, D, Quinto Olegario, K, Stewart, C, Wilson, G, Yan, E, Zhou, D, and Zurlo, M.

Published
2011

49. OC18.01:.

Author

Morency, A., Hodges, R., Keunen, J., Windrim, R., Seaward, G., and Ryan, G.

Abstract

An abstract of the article "Stage-based outcomes for 400 cases of TTTS managed with fetoscopic laser ablation of placental anastomoses" by A. Morency is presented.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results